Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
29,067,614
-
Total 13F shares
-
9,765,134
-
Share change
-
+3,112,524
-
Total reported value
-
$393,197,420
-
Price per share
-
$40.27
-
Number of holders
-
75
-
Value change
-
+$130,560,730
-
Number of buys
-
55
-
Number of sells
-
25
Institutional Holders of Krystal Biotech, Inc. - COMMON STOCK (KRYS) as of Q2 2019
As of 30 Jun 2019,
Krystal Biotech, Inc. - COMMON STOCK (KRYS) was held by
75 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
9,765,134 shares.
The largest 10 holders included
FMR LLC, Redmile Group, LLC, BAKER BROS. ADVISORS LP, PRICE T ROWE ASSOCIATES INC /MD/, FRAZIER MANAGEMENT LLC, ORBIMED ADVISORS LLC, BlackRock Inc., CITADEL ADVISORS LLC, VANGUARD GROUP INC, and Artal Group S.A..
This page lists
75
institutional shareholders reporting positions in this security
for the Q2 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.